Literature DB >> 2517566

[Isolation of Trypanosoma cruzi samples by xenodiagnosis and hemoculture from patients with chronic Chagas' disease].

E Bronfen1, F S de Assis Rocha, G B Machado, M M Perillo, A J Romanha, E Chiari.   

Abstract

Fifty nine chronic chagasic patients were simultaneously submitted to xenodiagnosis and hemoculture for Trypanosoma cruzi samples isolations. The xenodiagnosis was done with 40 Panstrongylus megistus, Triatoma infestans and Dipetalogaster maximus nymphs, performing 120 triatomines. Groups of 10 insects per specie were dissecated and the intestinal content pooled and examined, after previous trituration and homogenization. The microscopically negative material was seed into LIT medium and examined after 20 days. Twenty nine patients were parasitologically proved, being 15 only by xenodiagnosis, 4 only by hemoculture and 10 by both methods. It was discussed the parasitological comprovation difficulties in chronic chagasic patients, the value of the simultaneous utilization of different triatomine species in xenodiagnosis and the hemoculture, in a favorable positive association to the sensitivity increase in the diagnosis' disease. The 49.2% of positivity obtained in this group, visualize approaches like clinic-therapeutic assay and or epidemiological (case-control) with the purpose to investigate a possible association with T. cruzi samples and different clinic forms in Chagas' disease.

Entities:  

Mesh:

Year:  1989        PMID: 2517566     DOI: 10.1590/s0074-02761989000200012

Source DB:  PubMed          Journal:  Mem Inst Oswaldo Cruz        ISSN: 0074-0276            Impact factor:   2.743


  10 in total

1.  Arylimidamide DB766, a potential chemotherapeutic candidate for Chagas' disease treatment.

Authors:  Denise da Gama Jaén Batista; Marcos Meuser Batista; Gabriel Melo de Oliveira; Patrícia Borges do Amaral; Joseli Lannes-Vieira; Constança Carvalho Britto; Angela Junqueira; Marli Maria Lima; Alvaro José Romanha; Policarpo Ademar Sales Junior; Chad E Stephens; David W Boykin; Maria de Nazaré Correia Soeiro
Journal:  Antimicrob Agents Chemother       Date:  2010-05-10       Impact factor: 5.191

2.  Use of the Trypanosoma cruzi recombinant complement regulatory protein to evaluate therapeutic efficacy following treatment of chronic chagasic patients.

Authors:  Wendell S F Meira; Lúcia M C Galvão; Eliane D Gontijo; George L L Machado-Coelho; Karen A Norris; Egler Chiari
Journal:  J Clin Microbiol       Date:  2004-02       Impact factor: 5.948

3.  Detection of parasitemia profiles by blood culture after treatment of human chronic Trypanosoma cruzi infection.

Authors:  Ana Maria de Castro; Alejandro Ostermayer Luquetti; Anis Rassi; Egler Chiari; Lúcia Maria da Cunha Galvão
Journal:  Parasitol Res       Date:  2006-03-29       Impact factor: 2.289

4.  Multiple Approaches to Address Potential Risk Factors of Chagas Disease Transmission in Northeastern Brazil.

Authors:  Natalia Faria Daflon-Teixeira; Carolina Coutinho; Taís Ferreira Gomes; Helena Keiko Toma; Rosemere Duarte; Márcio Neves Bóia; Filipe Anibal Carvalho-Costa; Carlos Eduardo Almeida; Marli Maria Lima
Journal:  Am J Trop Med Hyg       Date:  2019-02       Impact factor: 2.345

5.  Serodiagnosis of Chagas' disease by enzyme-linked immunosorbent assay using two synthetic peptides as antigens.

Authors:  J M Peralta; M G Teixeira; W G Shreffler; J B Pereira; J M Burns; P R Sleath; S G Reed
Journal:  J Clin Microbiol       Date:  1994-04       Impact factor: 5.948

6.  Trypanosoma cruzi experimental congenital transmission associated with TcV and TcI subpatent maternal parasitemia.

Authors:  Sandra Maria Alkmim-Oliveira; André Guilherme Costa-Martins; Henrique Borges Kappel; Dalmo Correia; Luis Eduardo Ramirez; Eliane Lages-Silva
Journal:  Parasitol Res       Date:  2012-11-18       Impact factor: 2.289

7.  Homogeneity of Trypanosoma cruzi I, II, and III populations and the overlap of wild and domestic transmission cycles by Triatoma brasiliensis in northeastern Brazil.

Authors:  Antonia Cláudia Jácome da Câmara; Eliane Lages-Silva; George Harisson Felinto Sampaio; Daniella Alchaar D'Ávila; Egler Chiari; Lúcia Maria da Cunha Galvão
Journal:  Parasitol Res       Date:  2013-01-31       Impact factor: 2.289

8.  PCR assay for monitoring Trypanosoma cruzi parasitemia in childhood after specific chemotherapy.

Authors:  Lúcia M C Galvão; Egler Chiari; Andréa M Macedo; Alejandro O Luquetti; Simonne A Silva; Ana Lúcia S S Andrade
Journal:  J Clin Microbiol       Date:  2003-11       Impact factor: 5.948

9.  Trypanocidal effect of the benzyl ester of N-propyl oxamate: a bi-potential prodrug for the treatment of experimental Chagas disease.

Authors:  Carlos Wong-Baeza; Benjamín Nogueda-Torres; Manuel Serna; Sergio Meza-Toledo; Isabel Baeza; Carlos Wong
Journal:  BMC Pharmacol Toxicol       Date:  2015-04-22       Impact factor: 2.483

10.  Participation of Trypanosoma cruzi gp63 molecules on the interaction with Rhodnius prolixus.

Authors:  Karina M Rebello; Livia A Uehara; Vítor Ennes-Vidal; Aline S Garcia-Gomes; Constança Britto; Patrícia Azambuja; Rubem F S Menna-Barreto; André L S Santos; Marta H Branquinha; Claudia M d'Avila-Levy
Journal:  Parasitology       Date:  2019-05-06       Impact factor: 3.234

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.